1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generics in Japan, MarketLine

Generics in Japan, MarketLine

  • January 2016
  • -
  • MarketLine
  • -
  • 33 pages

Summary

Table of Contents

Search Inside

Introduction

Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

- The Japanese generics market is expected to generate total revenues of $10.2bn in 2015, representing a compound annual growth rate (CAGR) of 2.5% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 43.4 % of total pharma volume in 2015.

- Unlike its G8 peers, generic market share in Japan is rather low. Due to an aging population and rising costs of branded drugs, healthcare policies to cut expenditure on medical costs have been implemented. These policies aim to increase generic market share to 80% of volume between 2018 and 2020.

Features

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Japan

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Japan

- Leading company profiles reveal details of key generics market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Japan generics market with five year forecasts by both value and volume

- Macroeconomic indicators provide insight into general trends within the Japan economy

Key Questions Answered

- What was the size of the Japan generics market by value in 2015?

- What will be the size of the Japan generics market in 2020?

- What factors are affecting the strength of competition in the Japan generics market?

- How has the market performed over the last five years?

- How large is Japan’s generics market in relation to its regional counterparts?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.